CEFIXIME, INVITRO ACTIVITY, PHARMACOKINETICS AND TISSUE PENETRATION

被引:36
作者
STONE, JW
LINONG, G
ANDREWS, JM
WISE, R
机构
关键词
D O I
10.1093/jac/23.2.221
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:221 / 228
页数:8
相关论文
共 15 条
[1]  
BAUERNFEIND A, 1985, 14TH P WORKSH INT C, P11
[2]   INVITRO ACTIVITY OF DIFLOXACIN HYDROCHLORIDE (A-56619), A-56620, AND CEFIXIME (CL 284,635-FK 027) AGAINST SELECTED GENITAL PATHOGENS [J].
BOWIE, WR ;
SHAW, CE ;
CHAN, DGW ;
BOYD, J ;
BLACK, WA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :590-593
[3]   THE PHARMACOKINETIC AND BACTERICIDAL CHARACTERISTICS OF ORAL CEFIXIME [J].
BRITTAIN, DC ;
SCULLY, BE ;
HIROSE, T ;
NEU, HC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :590-594
[4]  
GLADTKE E, 1979, PHARMACOKINETICS INT, P58
[5]   DRUG-THERAPY - CLINICAL PHARMACOKINETICS .1. [J].
GREENBLATT, DJ ;
KOCHWESER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :702-705
[6]   PHARMACOKINETICS OF CEFIXIME (CL-284,635, FK-027) IN HEALTHY-SUBJECTS AND PATIENTS WITH RENAL-INSUFFICIENCY [J].
GUAY, DRP ;
MEATHERALL, RC ;
HARDING, GK ;
BROWN, GR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :485-490
[7]  
NAKASHIMA M, 1986, JPN CLIN PHARM THER, V17, P559
[8]   COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].
NEU, HC ;
CHIN, NX ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180
[9]   COMPARATIVE HUMAN ORAL CLINICAL PHARMACOLOGY OF CEFADROXIL, CEPHALEXIN, AND CEPHRADINE [J].
PFEFFER, M ;
JACKSON, A ;
XIMENES, J ;
PERCHEDEMENEZES, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) :331-338
[10]  
SAITO A, 1984, 31ST ANN M E BRANCH